ECM
TGTX icon

Evergreen Capital Management’s TG Therapeutics TGTX Stock Holding History

Evergreen Capital Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
+11,785
New +$482K 0.01% 750
2025
Q2 		– Sell
-6,853
Closed -$270K – 1251
2025
Q1 		$270K Buy
+6,853
New +$231K 0.01% 814

Other funds holding TGTX

CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return

Evergreen Capital Management's TGTX Position: Q2 2026 in Review

Evergreen Capital Management opened a new position in TG Therapeutics (TGTX) in Q2 2026: 11,785 shares worth $647K. The stake represents 0.01% of the portfolio and ranks #750 among its holdings. This is a return to the name: Evergreen Capital Management previously reported a position in TGTX as recently as Q1 2025.

Evergreen Capital Management first reported a position in TGTX in Q1 2025 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Evergreen Capital Management held 11,785 shares of TG Therapeutics worth $647K as of Q2 2026.
  • TG Therapeutics was a new Evergreen Capital Management position in Q2 2026.
  • TG Therapeutics made up 0.01% of Evergreen Capital Management's portfolio in Q2 2026, its #750 holding.
  • Evergreen Capital Management first reported a position in TG Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Evergreen Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.